limosilactobacillus fermentum

Limosilactobacillus fermentum is a probiotic bacterial species used as a strain-level therapeutic ingredient in microbiome-directed products, fermented foods, and dietary supplement formulations. It is not a single chemically defined drug substance but a live microbial active ingredient whose proposed therapeutic effects are mediated through modulation of gut and mucosal microbiota, reinforcement of epithelial barrier function, competition with potentially pathogenic organisms, and immunomodulatory and antioxidant effects. The provided evidence supports clinical and preclinical investigation of specific L. fermentum strains in conditions including atopic dermatitis, asthma, low anterior resection syndrome, osteoporosis, periodontitis, adiposity-related metabolic outcomes, and chronic kidney disease models, with activity appearing to be strain specific rather than uniform across the species. The exact developer and product characteristics therefore depend on the particular strain or formulation; examples in the provided context include HEM Pharma's HEM1036 program and academic strain programs such as CCFM1126, CCFM1139, and PTCC 1744.

Other names

Limosilactobacillus fermentumLactobacillus fermentum发酵乳杆菌